85 related articles for article (PubMed ID: 5363860)
21. Criteria for the classification of early systemic sclerosis.
LeRoy EC; Medsger TA
J Rheumatol; 2001 Jul; 28(7):1573-6. PubMed ID: 11469464
[TBL] [Abstract][Full Text] [Related]
22. [Classification of systemic progressive sclerosis].
Reumatizam; 1996; 43(1):25-7. PubMed ID: 8966376
[No Abstract] [Full Text] [Related]
23. Childhood systemic sclerosis.
Zulian F; Martini G
Curr Opin Rheumatol; 2007 Nov; 19(6):592-7. PubMed ID: 17917540
[TBL] [Abstract][Full Text] [Related]
24. [Determination of muscle microcirculation in the extremities of normal subjects and patients with scleroderma using 133Xenon-clearance. 2. Study of patients with progressive scleroderma].
Pönitzsch I; Wiemers U; Haustein UF; Schneider G
Radiobiol Radiother (Berl); 1984; 25(2):349-53. PubMed ID: 6739777
[No Abstract] [Full Text] [Related]
25. The many faces of scleroderma.
Steen VD
Rheum Dis Clin North Am; 2008 Feb; 34(1):1-15; v. PubMed ID: 18329529
[TBL] [Abstract][Full Text] [Related]
26. De novo systemic sclerosis after radiotherapy: a report of 3 cases.
Darras-Joly C; Wechsler B; Blétry O; Piette JC
J Rheumatol; 1999 Oct; 26(10):2265-7. PubMed ID: 10529153
[TBL] [Abstract][Full Text] [Related]
27. Revising the classification criteria for systemic sclerosis.
Nadashkevich O; Davis P; Fritzler MJ
Arthritis Rheum; 2006 Dec; 55(6):992-3. PubMed ID: 17139623
[No Abstract] [Full Text] [Related]
28. [Progressive scleroderma].
Schmitz-Moormann P; Seybold D
Med Welt; 1971 Mar; 13():487-90. PubMed ID: 5563470
[No Abstract] [Full Text] [Related]
29. Scleroderma--clinical and pathological advances.
Denton CP; Black CM
Best Pract Res Clin Rheumatol; 2004 Jun; 18(3):271-90. PubMed ID: 15158741
[TBL] [Abstract][Full Text] [Related]
30. Sclerodermatous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: incidence, predictors and outcome.
Skert C; Patriarca F; Sperotto A; Cerno M; Filì C; Zaja F; Stocchi R; Geromin A; Damiani D; Fanin R
Haematologica; 2006 Feb; 91(2):258-61. PubMed ID: 16461315
[TBL] [Abstract][Full Text] [Related]
31. [Contribution to the etiology and therapy of scleroderma].
Schmechel A
Dermatol Wochenschr; 1966 Nov; 152(47):1306-10. PubMed ID: 5978773
[No Abstract] [Full Text] [Related]
32. [Therapeutic trial with fucidin in systemic scleroderma].
Rubisz-Brzezińska J; Zebracka T; Mozdzanowski J; Mozdzanowska K
Z Hautkr; 1984 Dec; 59(23):1611-9. PubMed ID: 6395525
[TBL] [Abstract][Full Text] [Related]
33. Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma.
Lonzetti LS; Joyal F; Raynauld JP; Roussin A; Goulet JR; Rich E; Choquette D; Raymond Y; Senécal JL
Arthritis Rheum; 2001 Mar; 44(3):735-6. PubMed ID: 11263791
[No Abstract] [Full Text] [Related]
34. A clinical study of scleroderma cases.
Chakravarty J
Indian J Dermatol; 1966 Jul; 11(4):109-12. PubMed ID: 5969950
[No Abstract] [Full Text] [Related]
35. [The clinical picture of morphea].
Wojas-Pelc A; Wielowieyska-Szybińska D
Przegl Lek; 2007; 64(6):438-41. PubMed ID: 18159855
[TBL] [Abstract][Full Text] [Related]
36. Estimating the burden of scleroderma disease in Spain.
Villaverde-Hueso A; Sánchez-Valle E; Alvarez E; Morant C; Carreira PE; Martín-Arribas MC; Gènova R; Ramírez-González A; de la Paz MP
J Rheumatol; 2007 Nov; 34(11):2236-42. PubMed ID: 17918783
[TBL] [Abstract][Full Text] [Related]
37. [Esophageal involvement in progressive systemic sclerosis].
Monastra Varrica L; Doweck J; Améndola R; Farías R; Schenone L; Bori J; Fiorini A; Musi AO; Corti RE
Acta Gastroenterol Latinoam; 1994; 24(4):245-9. PubMed ID: 7701909
[TBL] [Abstract][Full Text] [Related]
38. Predictors of the scleroderma phenotype in fibroblasts from systemic sclerosis patients.
Qi Q; Guo Q; Tan G; Mao Y; Tang H; Zhou C; Zeng F
J Eur Acad Dermatol Venereol; 2009 Feb; 23(2):160-8. PubMed ID: 19054252
[TBL] [Abstract][Full Text] [Related]
39. Microchimerism in systemic sclerosis: comment on the article by Johnson et al.
Roberts-Thomson PJ; Walker JG; Hakendorf P; Smith MD; Ahern MJ
Arthritis Rheum; 2002 Sep; 46(9):2538; author reply 2538-9. PubMed ID: 12355505
[No Abstract] [Full Text] [Related]
40. Scleroderma--developing measures of response.
Furst DE; Khanna D; Mattucci-Cerinic M; Silman AJ; Merkel PA; Foeldvari I;
J Rheumatol; 2005 Dec; 32(12):2477-80. PubMed ID: 16331791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
